Safety and clinical efficacy of the secretome of stressed peripheral blood mononuclear cells in patients with diabetic foot ulcer—study protocol of the randomized, placebo-controlled, double-blind, multicenter, international phase II clinical trial MARSYAS II

被引：0
|
作者：
Alfred Gugerell
Ghazaleh Gouya-Lechner
Helmut Hofbauer
Maria Laggner
Franz Trautinger
Gabriele Almer
Anja Peterbauer-Scherb
Marcus Seibold
Wolfram Hoetzenecker
Christiane Dreschl
Michael Mildner
Hendrik Jan Ankersmit
机构：
[1] Medical University of Vienna,Division of Thoracic Surgery
[2] Aposcience AG,Clinical Department for Skin and Venereal Diseases
[3] Universitaetsklinikum St.Poelten,Department of Dermatology and Venerology
[4] Austrian Red Cross Blood Transfusion Service of Upper Austria,Department of Surgery
[5] Kepler University Hospital,Research Division of Biology and Pathobiology of the Skin, Department of Dermatology
[6] Krankenhaus der Elisabethinen Klagenfurt,undefined
[7] Medical University of Vienna,undefined
来源：
Trials | / 22卷
关键词：
Diabetic foot ulcer; Secretome-based therapy; Peripheral blood mononuclear cells; Skin; Inflammation; (Impaired) wound healing; Biological; Hydrogel; Clinical trial protocol; Randomized controlled trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Safety and clinical efficacy of the secretome of stressed peripheral blood mononuclear cells in patients with diabetic foot ulcer-study protocol of the randomized, placebo-controlled, double-blind, multicenter, international phase II clinical trial MARSYAS II
    Gugerell, Alfred
    Gouya-Lechner, Ghazaleh
    Hofbauer, Helmut
    Laggner, Maria
    Trautinger, Franz
    Almer, Gabriele
    Peterbauer-Scherb, Anja
    Seibold, Marcus
    Hoetzenecker, Wolfram
    Dreschl, Christiane
    Mildner, Michael
    Ankersmit, Hendrik Jan
    TRIALS, 2021, 22 (01)
  • [2] The efficacy and safety of Hanslim for obese patients Study protocol for a multicenter, randomized, double-blind, multi-dose, placebo-controlled, phase IIb clinical trial
    Lee, Seunghoon
    Lee, Hyeonhoon
    Cho, Yeeun
    Kim, Jihye
    Kang, Jung Won
    Seo, Byung-Kwan
    Baek, Yong-Hyeon
    Lee, Jae-Dong
    MEDICINE, 2018, 97 (38)
  • [3] A randomized, double-blind, placebo-controlled, multicenter Phase II clinical trial of fruquintinib in patients with metastatic colorectal cancer (mCRC)
    Li, J.
    Xu, R.
    Bai, Y.
    Xu, J.
    Liu, T.
    Shen, L.
    Wang, L.
    Pan, H.
    Fan, S.
    Hua, Y.
    Su, W.
    Hugg, C.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S366 - S366
  • [4] Efficacy and safety of herbal medicine (Binafuxi granules) for the common cold with fever: A multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial
    Liu, Xuemei
    Min, Jie
    She, Bin
    Chen, Yan
    Li, Jun
    Huang, Lei
    Chen, Ju
    Luo, Ai
    Yang, Mei
    Li, Ting
    Wu, Yanqing
    Chen, Daohong
    Zhong, Hongli
    Liu, Wei
    Mao, Bing
    Jiang, Hongli
    INTEGRATIVE MEDICINE RESEARCH, 2023, 12 (03)
  • [5] Efficacy and Safety of Zihua Wenfei Zhisou Granule in Treatment of Postinfectious Cough: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Clinical Trial
    Li, Ting
    Liu, Xue-mei
    Yang, Mei
    Wu, Yan-qing
    Liu, Wei
    Mao, Bing
    Jiang, Hong-li
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2025, 31 (01) : 3 - 10
  • [6] Efficacy and safety of Yirui capsule in patients with hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
    Liang Dai
    Linda L. D. Zhong
    Yan Cao
    Wei Chen
    Ying Cheng
    Xiu-Fang Lin
    Zhao-Xiang Bian
    Ai-Ping Lu
    Trials, 17
  • [7] Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial
    Chen, Qi
    Wang, Zi
    Lv, Jicheng
    Liu, Lijun
    Li, Hang
    Sun, Weiwei
    Huo, Yanhong
    Guo, Yingbo
    Shen, Cun
    Li, Shichao
    Chen, Zhenjie
    Zhou, Jingwei
    TRIALS, 2022, 23 (01)
  • [8] Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial
    Qi Chen
    Zi Wang
    Jicheng Lv
    Lijun Liu
    Hang Li
    Weiwei Sun
    Yanhong Huo
    Yingbo Guo
    Cun Shen
    Shichao Li
    Zhenjie Chen
    Jingwei Zhou
    Trials, 23
  • [9] Efficacy and safety of Yirui capsule in patients with hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
    Dai, Liang
    Zhong, Linda L. D.
    Cao, Yan
    Chen, Wei
    Cheng, Ying
    Lin, Xiu-Fang
    Bian, Zhao-Xiang
    Lu, Ai-Ping
    TRIALS, 2016, 17
  • [10] A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma
    Cui, Chuanliang
    Mao, Lili
    Chi, Zhihong
    Si, Lu
    Sheng, Xinan
    Kong, Yan
    Li, Siming
    Lian, Bin
    Gu, Kangsheng
    Tao, Min
    Song, Xin
    Lin, Tongyu
    Ren, Xiubao
    Qin, Shukui
    Guo, Jun
    MOLECULAR THERAPY, 2013, 21 (07) : 1456 - 1463
12345